151 related articles for article (PubMed ID: 35780804)
21. Variations in red blood cell polyamines in brain tumour patients treated with stereotactic radiosurgery.
von Essen C; Elworthy P; Hitchcock E
Neurol Res; 1989 Jun; 11(2):76-8. PubMed ID: 2569685
[TBL] [Abstract][Full Text] [Related]
22. Cerebrovascular events, secondary intracranial tumors, and mortality after radiotherapy for nonfunctioning pituitary adenomas: a subanalysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Ubachs DH; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
J Clin Endocrinol Metab; 2015 Mar; 100(3):1104-12. PubMed ID: 25574793
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome in children with recurrent craniopharyngioma after primary surgery.
Kalapurakal JA; Goldman S; Hsieh YC; Tomita T; Marymont MH
Cancer J; 2000; 6(6):388-93. PubMed ID: 11131489
[TBL] [Abstract][Full Text] [Related]
24. CT-guided stereotactic injection of radionuclide for treatment of brain tumors.
Tian ZM; Liu ZH; Kang GQ; Zhang Y; Li SY; Chen XH; Chui Y; Feng H
Stereotact Funct Neurosurg; 1992; 59(1-4):169-73. PubMed ID: 1295037
[TBL] [Abstract][Full Text] [Related]
25. Preoperative Evaluation of Sellar and Parasellar Macrolesions by [
Tosaka M; Higuchi T; Horiguchi K; Osawa T; Arisaka Y; Fujita H; Tsushima Y; Yoshimoto Y
World Neurosurg; 2017 Jul; 103():591-599. PubMed ID: 28427982
[TBL] [Abstract][Full Text] [Related]
26. Discrimination between pituitary adenoma and craniopharyngioma using MRI-based image features and texture features.
Zhang Y; Chen C; Tian Z; Xu J
Jpn J Radiol; 2020 Dec; 38(12):1125-1134. PubMed ID: 32710133
[TBL] [Abstract][Full Text] [Related]
27. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas.
Minniti G; Saran F; Traish D; Soomal R; Sardell S; Gonsalves A; Ashley S; Warrington J; Burke K; Mosleh-Shirazi A; Brada M
Radiother Oncol; 2007 Jan; 82(1):90-5. PubMed ID: 17161483
[TBL] [Abstract][Full Text] [Related]
28. [New indications of protontherapy for adults intracranial tumours].
Lesueur P; Doyen J; Lecornu M; Calugaru V; Florescu C; Missohou F; Geffrelot J; Mammar H; Stefan D; Feuvret L; Balosso J
Cancer Radiother; 2021 Oct; 25(6-7):545-549. PubMed ID: 34175224
[TBL] [Abstract][Full Text] [Related]
29. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas.
Brada M; Rajan B; Traish D; Ashley S; Holmes-Sellors PJ; Nussey S; Uttley D
Clin Endocrinol (Oxf); 1993 Jun; 38(6):571-8. PubMed ID: 8334743
[TBL] [Abstract][Full Text] [Related]
30. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk.
Tsang RW; Laperriere NJ; Simpson WJ; Brierley J; Panzarella T; Smyth HS
Cancer; 1993 Oct; 72(7):2227-33. PubMed ID: 8374881
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques.
Minniti G; Jaffrain-Rea ML; Osti M; Cantore G; Enrici RM
Neurosurg Rev; 2007 Jul; 30(3):167-75; discussion 175-6. PubMed ID: 17483973
[TBL] [Abstract][Full Text] [Related]
32. Collision of Craniopharyngioma and Pituitary Adenoma: Comprehensive Review of an Extremely Rare Sellar Condition.
Hasegawa H; Jentoft ME; Young WF; Lakomkin N; Van Gompel JJ; Link MJ; Atkinson JL; Meyer FB
World Neurosurg; 2021 May; 149():e51-e62. PubMed ID: 33647491
[TBL] [Abstract][Full Text] [Related]
33. Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas.
Lastoria S; Colao A; Vergara E; Ferone D; Varrella P; Merola B; Lombardi G; Salvatore M
Eur J Endocrinol; 1995 Jul; 133(1):38-47. PubMed ID: 7627336
[TBL] [Abstract][Full Text] [Related]
34. Modeling intracranial second tumor risk and estimates of clinical toxicity with various radiation therapy techniques for patients with pituitary adenoma.
Winkfield KM; Niemierko A; Bussiere MR; Crowley EM; Napolitano BN; Beaudette KP; Loeffler JS; Shih HA
Technol Cancer Res Treat; 2011 Jun; 10(3):243-51. PubMed ID: 21517130
[TBL] [Abstract][Full Text] [Related]
35. Clinical equipoise: Protons and the child with craniopharyngioma.
Conroy R; Gomes L; Owen C; Buchsbaum J; Ahern V
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):379-85. PubMed ID: 25487038
[TBL] [Abstract][Full Text] [Related]
36. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours.
Norberg L; Johansson R; Rasmuson T
Clin Endocrinol (Oxf); 2008 May; 68(5):780-5. PubMed ID: 17980004
[TBL] [Abstract][Full Text] [Related]
37. The incidence of cerebrovascular accidents in patients with pituitary adenoma.
Brada M; Burchell L; Ashley S; Traish D
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):693-8. PubMed ID: 10524424
[TBL] [Abstract][Full Text] [Related]
38. Interstitial irradiation of skull base tumours.
Bernstein M; Gutin PH
Can J Neurol Sci; 1985 Nov; 12(4):366-70. PubMed ID: 3910210
[TBL] [Abstract][Full Text] [Related]
39. Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962-1990.
Bliss P; Kerr GR; Gregor A
Clin Oncol (R Coll Radiol); 1994; 6(6):361-3. PubMed ID: 7873481
[TBL] [Abstract][Full Text] [Related]
40. Malignant glioma as a secondary malignant neoplasm after radiation therapy for craniopharyngioma: report of a case and review of reported cases.
Kranzinger M; Jones N; Rittinger O; Pilz P; Piotrowski WP; Manzl M; Galvan G; Kogelnik HD
Onkologie; 2001 Feb; 24(1):66-72. PubMed ID: 11441284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
